Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DIVALPROEX SODIUM

DIVALPROEX SODIUM

Standard Dose
EQ 500MG VALPROIC ACID
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DIVALPROEX SODIUM is listed in Drugs@FDA under application 215527 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DIVALPROEX SODIUM Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID Sponsor ANNORA PHARMA Submission history Latest submission status date: 2025-04-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIVALPROEX SODIUM is listed in Drugs@FDA under application 215527 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DIVALPROEX SODIUM Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID Sponsor ANNORA PHARMA Submission history Latest submission status date: 2025-04-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DIVALPROEX SODIUM (DIVALPROEX SODIUM) | Drug Monograph | MedicHelpline